Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Navab

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Diabetes|October 1, 1992
Minimally modified lipoproteins in diabetesJ A Berliner, M Territo, M Navab, et al.
Current Opinion in Lipidology|September 18, 1998
Paraoxonase and coronary heart diseaseM I Mackness, B Mackness, P N Durrington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolaseC Lee, F Sigari, T Segrado, et al.
Circulation|May 1, 1995
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and geneticsJ A Berliner, M Navab, A M Fogelman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipidsS T Reddy, D J Wadleigh, V Grijalva, et al.
The Journal of Clinical Investigation|July 15, 1997
Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particlesL W Castellani, M Navab, B J Van Lenten, et al.
Journal of Lipid Research|April 6, 2001
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosisD W Garber, G Datta, M Chaddha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cellsS D Cushing, J A Berliner, A J Valente, et al.
The American Journal of Cardiology|September 28, 1995
Pathogenesis of atherosclerosisM Navab, A M Fogelman, J A Berliner, et al.
The Journal of Clinical Investigation|May 1, 1991
Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 messageM Navab, F Liao, G P Hough, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Diabetes|October 1, 1992
Minimally modified lipoproteins in diabetesJ A Berliner, M Territo, M Navab, et al.
Current Opinion in Lipidology|September 18, 1998
Paraoxonase and coronary heart diseaseM I Mackness, B Mackness, P N Durrington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolaseC Lee, F Sigari, T Segrado, et al.
Circulation|May 1, 1995
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and geneticsJ A Berliner, M Navab, A M Fogelman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 17, 2001
Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipidsS T Reddy, D J Wadleigh, V Grijalva, et al.
The Journal of Clinical Investigation|July 15, 1997
Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particlesL W Castellani, M Navab, B J Van Lenten, et al.
Journal of Lipid Research|April 6, 2001
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosisD W Garber, G Datta, M Chaddha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cellsS D Cushing, J A Berliner, A J Valente, et al.
The American Journal of Cardiology|September 28, 1995
Pathogenesis of atherosclerosisM Navab, A M Fogelman, J A Berliner, et al.
The Journal of Clinical Investigation|May 1, 1991
Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 messageM Navab, F Liao, G P Hough, et al.
Pageof 7